Physician profile
Robert C Long
NPI 1639383532
$1,015,392.32
in general payments reported to CMS, 2019-2025
49 companies · $95K in 2025
The $95K reported for 2025 was more than what 97% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $135K · 2021: $190K · 2022: $205K · 2023: $227K · 2024: $129K · 2025: $95K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $334K · Consulting Fee: $53K · Travel and Lodging: $51K · Food and Beverage: $12K · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $334,473.50 |
| Consulting Fee | $52,587.20 |
| Travel and Lodging | $51,397.18 |
| Food and Beverage | $11,702.02 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $427,770.32 | 2019-2025 | Farxiga, Lokelma, Brilinta |
| Merck Sharp & Dohme LLC | $292,447.40 | 2021-2025 | Verquvo, Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108,047.91 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $59,801.04 | 2019-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $39,097.31 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $33,368.93 | 2025 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $25,853.47 | 2019-2025 | |
| Lilly USA, LLC | $16,239.09 | 2022-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $3,869.32 | 2020-2025 | Uptravi, Opsumit |
| Abiomed | $1,865.22 | 2019-2025 | Impella |
| One Lambda, INC. | $1,202.97 | 2024 | |
| Pfizer INC. | $766.30 | 2019-2025 | |
| United Therapeutics Corporation | $755.33 | 2019-2025 | Tyvaso, Remodulin, Remodulin |
| Janssen Pharmaceuticals, INC | $384.42 | 2019-2024 | Xarelto |
| Vifor Pharma, INC. | $367.61 | 2019-2021 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $346.81 | 2021-2025 | Wegovy |
| Amgen INC. | $265.21 | 2019-2022 | |
| Livanova USA, INC. | $260.68 | 2019-2023 | Tandemlife |
| Abbott Laboratories | $232.34 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Irhythm Technologies, INC. | $227.40 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Inspire Medical Systems, INC. | $219.80 | 2024-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $189.06 | 2025 | Evkeeza |
| Stryker Corporation | $168.57 | 2025 | Clottriever Bold Catheter |
| Astellas Pharma US INC | $147.15 | 2019-2020 | |
| Edwards Lifesciences Corporation | $145.86 | 2024-2025 | Evoque, Sapien 3 Ultra Resilia |
| Lantheus Medical Imaging, INC. | $142.73 | 2019 | |
| Philips North America LLC | $131.00 | 2025 | Lm Undivided |
| Daxor Corporation | $129.58 | 2022 | |
| Chiesi USA, INC. | $125.11 | 2024-2025 | Kengreal, Juxtapid |
| Gilead Sciences, INC. | $108.49 | 2019 | |
| Idorsia Pharmaceuticals US INC | $108.16 | 2025 | Tryvio |
| Btg International INC. | $100.80 | 2019 | |
| Bridgebio Pharma, INC. | $86.33 | 2025 | Attruby |
| Braemar Manufacturing, LLC | $72.78 | 2019 | |
| Impulse Dynamics (USA) INC. | $63.00 | 2022-2023 | Optimizer |
| Medtronic, INC. | $45.90 | 2022-2024 | |
| Medtronic Vascular, INC. | $38.91 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $37.23 | 2024 | Arcalyst |
| Sandoz INC. | $36.35 | 2025 | Treprostinil |
| Akcea Therapeutics, INC. | $28.63 | 2019 | |
| Dendreon Pharmaceuticals LLC | $24.83 | 2024 | Provenge |
| Procyrion, INC. | $23.60 | 2025 | Aortix System |
| Boston Scientific Corporation | $21.22 | 2025 | Watchman Access System |
| Biotronik INC. | $16.60 | 2019 | |
| Ge Healthcare | $11.55 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.